About the journal
Pharmacogenomics and Personalized Medicine is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1178-7066
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,565 USD
- Articles in DOAJ
- 687
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2009-07-14
- PUBMED · 2011-11-16
- Indexing
- DOAJ · PUBMED
- APC
- 3,565 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
687
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
704
Last recorded publication year
2026
h-index
45
i10-index
289
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2009-07-14
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 84%
- ORCID iDs in current deposits
- 69%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Pharmacogenomics and personalised medicine
- Source type
- journal
- NLM unique ID (PubMed)
- 101514107
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
Show all subjects (50)
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- RNA modifications and cancer
- RNA modifications and cancer
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Pharmacological Effects and Toxicity Studies
- Pain Management and Opioid Use
- Pain Management and Opioid Use
- Pharmacological Effects and Toxicity Studies
- Epigenetics and DNA Methylation
- Cancer Immunotherapy and Biomarkers
- Epigenetics and DNA Methylation
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Pharmaceutical studies and practices
- BRCA gene mutations in cancer
- Pharmaceutical studies and practices
- BRCA gene mutations in cancer
- Glutathione Transferases and Polymorphisms
- Glutathione Transferases and Polymorphisms
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- HER2/EGFR in Cancer Research
- Circular RNAs in diseases
- Circular RNAs in diseases
- HER2/EGFR in Cancer Research
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Lipoproteins and Cardiovascular Health
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Lipoproteins and Cardiovascular Health
- Lung Cancer Research Studies
- Lung Cancer Research Studies
Keywords (DOAJ)
- genomic profiling
- genetics
- pharmacology
- drug metabolism
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ